Transfusion-related Acute Lung Injury in the Critically Ill: Prospective Nested Case-Control Study

Acute lung injury (ALI) that develops 6 hours after transfusion (TRALI) is the leading cause of transfusion-related mortality. Several transfusion characteristics have been postulated as risk factors for TRALI, but the evidence is limited to retrospective studies. To compare patient and transfusion...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of respiratory and critical care medicine 2007-11, Vol.176 (9), p.886-891
Hauptverfasser: Gajic, Ognjen, Rana, Rimki, Winters, Jeffrey L, Yilmaz, Murat, Mendez, Jose L, Rickman, Otis B, O'Byrne, Megan M, Evenson, Laura K, Malinchoc, Michael, DeGoey, Steven R, Afessa, Bekele, Hubmayr, Rolf D, Moore, S. Breanndan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 891
container_issue 9
container_start_page 886
container_title American journal of respiratory and critical care medicine
container_volume 176
creator Gajic, Ognjen
Rana, Rimki
Winters, Jeffrey L
Yilmaz, Murat
Mendez, Jose L
Rickman, Otis B
O'Byrne, Megan M
Evenson, Laura K
Malinchoc, Michael
DeGoey, Steven R
Afessa, Bekele
Hubmayr, Rolf D
Moore, S. Breanndan
description Acute lung injury (ALI) that develops 6 hours after transfusion (TRALI) is the leading cause of transfusion-related mortality. Several transfusion characteristics have been postulated as risk factors for TRALI, but the evidence is limited to retrospective studies. To compare patient and transfusion risk factors between patients who do and do not develop ALI. In this prospective cohort study, consecutive transfused critically ill patients were closely observed for development of ALI. Donor samples were collected from the transfusion bags. Risk factors were compared between patients who developed ALI after transfusion and transfused control patients, matched by age, sex, and admission diagnosis. Seventy-four of 901 transfused patients developed ALI within 6 hours of transfusion (8%). Compared with transfused control subjects, patients with ALI were more likely to have sepsis (37 vs. 22%, P = 0.016) and a history of chronic alcohol abuse (37 vs. 18%, P = 0.006). When adjusted for patient characteristics, transfusion of plasma from female donors (odds ratio [OR], 5.09; 95% confidence interval [95% CI], 1.37-18.85) rather than male donors (OR, 1.60; 95% CI, 0.76 to 3.37), number of pregnancies among the donors (OR, 1.19; 95% CI, 1.05 to 1.34), number of donor units positive for anti-granulocyte antibodies (OR, 4.85; 95% CI, 1.32-17.86) and anti-HLA class II antibodies (OR, 3.08; 95% CI, 1.15-8.25), and concentration of lysophosphatidylcholine in the donor product (OR, 1.69; 95% CI, 1.10 to 2.59) were associated with the development of ALI. Both patient and transfusion risk factors determine the probability of ALI after transfusion. Transfusion factors represent attractive targets for the prevention of ALI.
doi_str_mv 10.1164/rccm.200702-271OC
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2048675</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68414645</sourcerecordid><originalsourceid>FETCH-LOGICAL-c282t-75652930b973f80c8221761e063b49ea9db1223e729be1e1630815f3763b0a073</originalsourceid><addsrcrecordid>eNpdkd2L1DAUxYso7of-Ab5I8EHYh665aZsPH4SlqDsw7Aqu4FtIM7czGdJ2NmlX5r83dYbV9SmB-zuHe-7JsjdALwF4-SFY210ySgVlORNwWz_LTqEqqrxUgj5PfyqKvCzVz5PsLMYtpcAk0JfZCQjOuAJ6mjV3wfSxnaIb-jygNyOuyJWdRiTLqV-TRb-dwp64nowbJHVwo7PG-z1ZeP-RfAtD3KEd3QOSG4yztjYR83roxzB48n2cVvtX2YvW-Iivj-959uPL57v6Ol_efl3UV8vcMsnGXFS8YqqgjRJFK6mVjKU1ASkvmlKhUasGGCtQMNUgIPCCSqjaQqQ5NSnpefbp4Lubmg5XFtMOxutdcJ0Jez0Yp59OerfR6-FBM1pKLqpk8P5oEIb7KcXRnYsWvTc9DlPUXJZQ8nIG3_0Hbocp9CmcBqUqRSsJCYIDZNORYsD2cROgeq5Pz_XpQ336T31J8_bfCH8Vx74ScHEANm69-eUC6tilOhIO2mxnw4RqpaXkxW8eVqUm</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>199590581</pqid></control><display><type>article</type><title>Transfusion-related Acute Lung Injury in the Critically Ill: Prospective Nested Case-Control Study</title><source>MEDLINE</source><source>American Thoracic Society (ATS) Journals Online</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><source>Journals@Ovid Complete</source><creator>Gajic, Ognjen ; Rana, Rimki ; Winters, Jeffrey L ; Yilmaz, Murat ; Mendez, Jose L ; Rickman, Otis B ; O'Byrne, Megan M ; Evenson, Laura K ; Malinchoc, Michael ; DeGoey, Steven R ; Afessa, Bekele ; Hubmayr, Rolf D ; Moore, S. Breanndan</creator><creatorcontrib>Gajic, Ognjen ; Rana, Rimki ; Winters, Jeffrey L ; Yilmaz, Murat ; Mendez, Jose L ; Rickman, Otis B ; O'Byrne, Megan M ; Evenson, Laura K ; Malinchoc, Michael ; DeGoey, Steven R ; Afessa, Bekele ; Hubmayr, Rolf D ; Moore, S. Breanndan</creatorcontrib><description>Acute lung injury (ALI) that develops 6 hours after transfusion (TRALI) is the leading cause of transfusion-related mortality. Several transfusion characteristics have been postulated as risk factors for TRALI, but the evidence is limited to retrospective studies. To compare patient and transfusion risk factors between patients who do and do not develop ALI. In this prospective cohort study, consecutive transfused critically ill patients were closely observed for development of ALI. Donor samples were collected from the transfusion bags. Risk factors were compared between patients who developed ALI after transfusion and transfused control patients, matched by age, sex, and admission diagnosis. Seventy-four of 901 transfused patients developed ALI within 6 hours of transfusion (8%). Compared with transfused control subjects, patients with ALI were more likely to have sepsis (37 vs. 22%, P = 0.016) and a history of chronic alcohol abuse (37 vs. 18%, P = 0.006). When adjusted for patient characteristics, transfusion of plasma from female donors (odds ratio [OR], 5.09; 95% confidence interval [95% CI], 1.37-18.85) rather than male donors (OR, 1.60; 95% CI, 0.76 to 3.37), number of pregnancies among the donors (OR, 1.19; 95% CI, 1.05 to 1.34), number of donor units positive for anti-granulocyte antibodies (OR, 4.85; 95% CI, 1.32-17.86) and anti-HLA class II antibodies (OR, 3.08; 95% CI, 1.15-8.25), and concentration of lysophosphatidylcholine in the donor product (OR, 1.69; 95% CI, 1.10 to 2.59) were associated with the development of ALI. Both patient and transfusion risk factors determine the probability of ALI after transfusion. Transfusion factors represent attractive targets for the prevention of ALI.</description><identifier>ISSN: 1073-449X</identifier><identifier>EISSN: 1535-4970</identifier><identifier>DOI: 10.1164/rccm.200702-271OC</identifier><identifier>PMID: 17626910</identifier><language>eng</language><publisher>United States: Am Thoracic Soc</publisher><subject>Aged ; Alcohol ; Antibodies ; B. Critical Care ; Blood &amp; organ donations ; Blood products ; Blood Transfusion - methods ; Case-Control Studies ; Cohort analysis ; Cohort Studies ; Critical Care ; Female ; Granulocytes ; Humans ; Incidence ; Leukocytes ; Male ; Middle Aged ; Mortality ; Patients ; Plasma ; Respiratory Distress Syndrome - epidemiology ; Respiratory Distress Syndrome - therapy ; Risk Factors ; Sepsis ; Time Factors ; Transfusion Reaction ; Treatment Outcome</subject><ispartof>American journal of respiratory and critical care medicine, 2007-11, Vol.176 (9), p.886-891</ispartof><rights>Copyright American Thoracic Society Nov 1, 2007</rights><rights>Copyright © 2007, American Thoracic Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c282t-75652930b973f80c8221761e063b49ea9db1223e729be1e1630815f3763b0a073</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,4011,4012,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17626910$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gajic, Ognjen</creatorcontrib><creatorcontrib>Rana, Rimki</creatorcontrib><creatorcontrib>Winters, Jeffrey L</creatorcontrib><creatorcontrib>Yilmaz, Murat</creatorcontrib><creatorcontrib>Mendez, Jose L</creatorcontrib><creatorcontrib>Rickman, Otis B</creatorcontrib><creatorcontrib>O'Byrne, Megan M</creatorcontrib><creatorcontrib>Evenson, Laura K</creatorcontrib><creatorcontrib>Malinchoc, Michael</creatorcontrib><creatorcontrib>DeGoey, Steven R</creatorcontrib><creatorcontrib>Afessa, Bekele</creatorcontrib><creatorcontrib>Hubmayr, Rolf D</creatorcontrib><creatorcontrib>Moore, S. Breanndan</creatorcontrib><title>Transfusion-related Acute Lung Injury in the Critically Ill: Prospective Nested Case-Control Study</title><title>American journal of respiratory and critical care medicine</title><addtitle>Am J Respir Crit Care Med</addtitle><description>Acute lung injury (ALI) that develops 6 hours after transfusion (TRALI) is the leading cause of transfusion-related mortality. Several transfusion characteristics have been postulated as risk factors for TRALI, but the evidence is limited to retrospective studies. To compare patient and transfusion risk factors between patients who do and do not develop ALI. In this prospective cohort study, consecutive transfused critically ill patients were closely observed for development of ALI. Donor samples were collected from the transfusion bags. Risk factors were compared between patients who developed ALI after transfusion and transfused control patients, matched by age, sex, and admission diagnosis. Seventy-four of 901 transfused patients developed ALI within 6 hours of transfusion (8%). Compared with transfused control subjects, patients with ALI were more likely to have sepsis (37 vs. 22%, P = 0.016) and a history of chronic alcohol abuse (37 vs. 18%, P = 0.006). When adjusted for patient characteristics, transfusion of plasma from female donors (odds ratio [OR], 5.09; 95% confidence interval [95% CI], 1.37-18.85) rather than male donors (OR, 1.60; 95% CI, 0.76 to 3.37), number of pregnancies among the donors (OR, 1.19; 95% CI, 1.05 to 1.34), number of donor units positive for anti-granulocyte antibodies (OR, 4.85; 95% CI, 1.32-17.86) and anti-HLA class II antibodies (OR, 3.08; 95% CI, 1.15-8.25), and concentration of lysophosphatidylcholine in the donor product (OR, 1.69; 95% CI, 1.10 to 2.59) were associated with the development of ALI. Both patient and transfusion risk factors determine the probability of ALI after transfusion. Transfusion factors represent attractive targets for the prevention of ALI.</description><subject>Aged</subject><subject>Alcohol</subject><subject>Antibodies</subject><subject>B. Critical Care</subject><subject>Blood &amp; organ donations</subject><subject>Blood products</subject><subject>Blood Transfusion - methods</subject><subject>Case-Control Studies</subject><subject>Cohort analysis</subject><subject>Cohort Studies</subject><subject>Critical Care</subject><subject>Female</subject><subject>Granulocytes</subject><subject>Humans</subject><subject>Incidence</subject><subject>Leukocytes</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Mortality</subject><subject>Patients</subject><subject>Plasma</subject><subject>Respiratory Distress Syndrome - epidemiology</subject><subject>Respiratory Distress Syndrome - therapy</subject><subject>Risk Factors</subject><subject>Sepsis</subject><subject>Time Factors</subject><subject>Transfusion Reaction</subject><subject>Treatment Outcome</subject><issn>1073-449X</issn><issn>1535-4970</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNpdkd2L1DAUxYso7of-Ab5I8EHYh665aZsPH4SlqDsw7Aqu4FtIM7czGdJ2NmlX5r83dYbV9SmB-zuHe-7JsjdALwF4-SFY210ySgVlORNwWz_LTqEqqrxUgj5PfyqKvCzVz5PsLMYtpcAk0JfZCQjOuAJ6mjV3wfSxnaIb-jygNyOuyJWdRiTLqV-TRb-dwp64nowbJHVwo7PG-z1ZeP-RfAtD3KEd3QOSG4yztjYR83roxzB48n2cVvtX2YvW-Iivj-959uPL57v6Ol_efl3UV8vcMsnGXFS8YqqgjRJFK6mVjKU1ASkvmlKhUasGGCtQMNUgIPCCSqjaQqQ5NSnpefbp4Lubmg5XFtMOxutdcJ0Jez0Yp59OerfR6-FBM1pKLqpk8P5oEIb7KcXRnYsWvTc9DlPUXJZQ8nIG3_0Hbocp9CmcBqUqRSsJCYIDZNORYsD2cROgeq5Pz_XpQ336T31J8_bfCH8Vx74ScHEANm69-eUC6tilOhIO2mxnw4RqpaXkxW8eVqUm</recordid><startdate>20071101</startdate><enddate>20071101</enddate><creator>Gajic, Ognjen</creator><creator>Rana, Rimki</creator><creator>Winters, Jeffrey L</creator><creator>Yilmaz, Murat</creator><creator>Mendez, Jose L</creator><creator>Rickman, Otis B</creator><creator>O'Byrne, Megan M</creator><creator>Evenson, Laura K</creator><creator>Malinchoc, Michael</creator><creator>DeGoey, Steven R</creator><creator>Afessa, Bekele</creator><creator>Hubmayr, Rolf D</creator><creator>Moore, S. Breanndan</creator><general>Am Thoracic Soc</general><general>American Thoracic Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20071101</creationdate><title>Transfusion-related Acute Lung Injury in the Critically Ill: Prospective Nested Case-Control Study</title><author>Gajic, Ognjen ; Rana, Rimki ; Winters, Jeffrey L ; Yilmaz, Murat ; Mendez, Jose L ; Rickman, Otis B ; O'Byrne, Megan M ; Evenson, Laura K ; Malinchoc, Michael ; DeGoey, Steven R ; Afessa, Bekele ; Hubmayr, Rolf D ; Moore, S. Breanndan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c282t-75652930b973f80c8221761e063b49ea9db1223e729be1e1630815f3763b0a073</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Aged</topic><topic>Alcohol</topic><topic>Antibodies</topic><topic>B. Critical Care</topic><topic>Blood &amp; organ donations</topic><topic>Blood products</topic><topic>Blood Transfusion - methods</topic><topic>Case-Control Studies</topic><topic>Cohort analysis</topic><topic>Cohort Studies</topic><topic>Critical Care</topic><topic>Female</topic><topic>Granulocytes</topic><topic>Humans</topic><topic>Incidence</topic><topic>Leukocytes</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Mortality</topic><topic>Patients</topic><topic>Plasma</topic><topic>Respiratory Distress Syndrome - epidemiology</topic><topic>Respiratory Distress Syndrome - therapy</topic><topic>Risk Factors</topic><topic>Sepsis</topic><topic>Time Factors</topic><topic>Transfusion Reaction</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gajic, Ognjen</creatorcontrib><creatorcontrib>Rana, Rimki</creatorcontrib><creatorcontrib>Winters, Jeffrey L</creatorcontrib><creatorcontrib>Yilmaz, Murat</creatorcontrib><creatorcontrib>Mendez, Jose L</creatorcontrib><creatorcontrib>Rickman, Otis B</creatorcontrib><creatorcontrib>O'Byrne, Megan M</creatorcontrib><creatorcontrib>Evenson, Laura K</creatorcontrib><creatorcontrib>Malinchoc, Michael</creatorcontrib><creatorcontrib>DeGoey, Steven R</creatorcontrib><creatorcontrib>Afessa, Bekele</creatorcontrib><creatorcontrib>Hubmayr, Rolf D</creatorcontrib><creatorcontrib>Moore, S. Breanndan</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>American journal of respiratory and critical care medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gajic, Ognjen</au><au>Rana, Rimki</au><au>Winters, Jeffrey L</au><au>Yilmaz, Murat</au><au>Mendez, Jose L</au><au>Rickman, Otis B</au><au>O'Byrne, Megan M</au><au>Evenson, Laura K</au><au>Malinchoc, Michael</au><au>DeGoey, Steven R</au><au>Afessa, Bekele</au><au>Hubmayr, Rolf D</au><au>Moore, S. Breanndan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Transfusion-related Acute Lung Injury in the Critically Ill: Prospective Nested Case-Control Study</atitle><jtitle>American journal of respiratory and critical care medicine</jtitle><addtitle>Am J Respir Crit Care Med</addtitle><date>2007-11-01</date><risdate>2007</risdate><volume>176</volume><issue>9</issue><spage>886</spage><epage>891</epage><pages>886-891</pages><issn>1073-449X</issn><eissn>1535-4970</eissn><abstract>Acute lung injury (ALI) that develops 6 hours after transfusion (TRALI) is the leading cause of transfusion-related mortality. Several transfusion characteristics have been postulated as risk factors for TRALI, but the evidence is limited to retrospective studies. To compare patient and transfusion risk factors between patients who do and do not develop ALI. In this prospective cohort study, consecutive transfused critically ill patients were closely observed for development of ALI. Donor samples were collected from the transfusion bags. Risk factors were compared between patients who developed ALI after transfusion and transfused control patients, matched by age, sex, and admission diagnosis. Seventy-four of 901 transfused patients developed ALI within 6 hours of transfusion (8%). Compared with transfused control subjects, patients with ALI were more likely to have sepsis (37 vs. 22%, P = 0.016) and a history of chronic alcohol abuse (37 vs. 18%, P = 0.006). When adjusted for patient characteristics, transfusion of plasma from female donors (odds ratio [OR], 5.09; 95% confidence interval [95% CI], 1.37-18.85) rather than male donors (OR, 1.60; 95% CI, 0.76 to 3.37), number of pregnancies among the donors (OR, 1.19; 95% CI, 1.05 to 1.34), number of donor units positive for anti-granulocyte antibodies (OR, 4.85; 95% CI, 1.32-17.86) and anti-HLA class II antibodies (OR, 3.08; 95% CI, 1.15-8.25), and concentration of lysophosphatidylcholine in the donor product (OR, 1.69; 95% CI, 1.10 to 2.59) were associated with the development of ALI. Both patient and transfusion risk factors determine the probability of ALI after transfusion. Transfusion factors represent attractive targets for the prevention of ALI.</abstract><cop>United States</cop><pub>Am Thoracic Soc</pub><pmid>17626910</pmid><doi>10.1164/rccm.200702-271OC</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1073-449X
ispartof American journal of respiratory and critical care medicine, 2007-11, Vol.176 (9), p.886-891
issn 1073-449X
1535-4970
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2048675
source MEDLINE; American Thoracic Society (ATS) Journals Online; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection; Journals@Ovid Complete
subjects Aged
Alcohol
Antibodies
B. Critical Care
Blood & organ donations
Blood products
Blood Transfusion - methods
Case-Control Studies
Cohort analysis
Cohort Studies
Critical Care
Female
Granulocytes
Humans
Incidence
Leukocytes
Male
Middle Aged
Mortality
Patients
Plasma
Respiratory Distress Syndrome - epidemiology
Respiratory Distress Syndrome - therapy
Risk Factors
Sepsis
Time Factors
Transfusion Reaction
Treatment Outcome
title Transfusion-related Acute Lung Injury in the Critically Ill: Prospective Nested Case-Control Study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T14%3A33%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Transfusion-related%20Acute%20Lung%20Injury%20in%20the%20Critically%20Ill:%20Prospective%20Nested%20Case-Control%20Study&rft.jtitle=American%20journal%20of%20respiratory%20and%20critical%20care%20medicine&rft.au=Gajic,%20Ognjen&rft.date=2007-11-01&rft.volume=176&rft.issue=9&rft.spage=886&rft.epage=891&rft.pages=886-891&rft.issn=1073-449X&rft.eissn=1535-4970&rft_id=info:doi/10.1164/rccm.200702-271OC&rft_dat=%3Cproquest_pubme%3E68414645%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=199590581&rft_id=info:pmid/17626910&rfr_iscdi=true